sur Kexing Biopharm
Kexing Biopharm Explores Global Expansion at CPHI Frankfurt 2025
From October 28th to 30th, Kexing Biopharm participated in CPHI Frankfurt 2025, a major pharmaceutical exhibition. The company highlighted its product portfolio and global commercialization strategies to a diverse international audience.
During the event, Kexing’s team engaged in discussions regarding product registration and market access, emphasizing localized collaboration. The company showcased its full-cycle pharmaceutical capabilities, supported by compliant quality and regulatory systems.
Kexing actively interacted with industry peers, gathering insights on market trends and policies. This experience will inform the company's strategy for further overseas expansion and potential client identification.
With a focus on international growth, Kexing continues to prioritize innovation in healthcare solutions, aiming to enhance global accessibility to quality medicine.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Kexing Biopharm